Skip to main content

Home / Publications / Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infections.

Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infections.

Walker AS, White IR, Turner RM, Hsu LY, Yeo TW, White NJ, Sharland M, Thwaites GE

Walker AS, White IR, Turner RM, Hsu LY, Yeo TW, White NJ, Sharland M, Thwaites GE

DOI: 10.1016/S1473-3099(20)30791-X
Type: Journal ArticleNon-U.S. Gov'tResearch SupportReview
Journal: LANCET INFECTIOUS DISEASES
Publication Date: 2021-06-01